Recevez
la newsletter

Actualités

Study:Multivitamins Won't Cut Women's Cancer,Heart Health Risk
By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- Taking a multivitamin didn't cut the risk of cancer, cardiovascular problems or dying among postmenopausal women, according to a new study released Monday.
The study, considered the largest multivitamin study in postmenopausal women conducted to date, was published in the Feb. 9 issue of the Archives of Internal Medicine.
Overall, it showed few differences in the risk of cancer, cardiovascular disease and dying from any cause between vitamin users and women who didn't take multivitamins.
Researchers, led by the Fred Hutchinson Cancer Research Center, in Seattle, analyzed data involving 161,808 women participating in the government-funded Women's Health Initiative, a clinical trial looking at the most common causes of death, disability and impaired quality of life in postmenopausal women. The initiative has looked at the effects of hormone-replacement therapy, diet and calcium, and now, multivitamins.
Women enrolled in the study between 1993 and 1998 and information about vitamin use was collected through interviews and by supplement bottles brought to clinic visits. A total of 41.5% of women reported using multivitamins. The women were followed through 2005 or about eight years.
In total, 9,619 cases of breast, colon, endometrial, renal, bladder, stomach, lung or ovarian cancer developed while 8,751 cardiovascular events, such as heart attack and stroke occurred. There were 9,865 deaths reported.
Women who took vitamins were more likely to be white, more physically active, more likely to use alchohol and less likely to smoke than non-vitamin users. There were few differences in disease outcomes between the vitamin and non-vitamin users, researchers said. They recommended that women focus on getting their nutrients from whole foods rather than vitamins.
"These results suggest that multivitamin use does not confer meaningful benefit or harm in relation to cancer or cardiovascular disease risk in postmenopausal women," researchers wrote.
The one exception to the overall finding was a possible lower risk of a heart attack among users of multivitamins with high doses of folic acid and B vitamins.
The study was funded by the National Heart, Lung and Blood Institute, a unit of the National Institutes of Health.
Previous findings of the Women's Health Initiative study showed that calcium slowed the loss of bone density over a seven-year period, but didn't significantly cut the rate of hip fractures. Calcium also didn't prevent colon cancer among the women in the study. However, another study from WHI suggested postmenopausal women who take calcium and vitamin D supplements may gain slightly less weight than women who don't, although the overall effect was small.
-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=BuCmGFFQrc67Caa%2Fmp1lvQ%3D%3D. You can use this link on the day this article is published and the following day.

Publié le 09 Février 2009 Copyright © 2009 Dowjones


Partager sur:


Partager sur Blogger Partager sur Delicious Partager sur Digg Partager sur Facebook Partager sur Furl Partager sur Linkedin Partager sur Myspace Partager sur Twitter Partager sur Technorati Partager sur Viadeo
CAC 40 3 729,36 Pts -0,82%

Palmarès

DANONE 41,30 € +1,57%
AIR LIQUIDE 78,20 € +0,64%
VEOLIA ENVIRO 23,08 € +0,54%
SOCIETE GENER 47,43 € -2,73%
UNIBAIL-RODAM 152,25 € -2,81%
STMICROELECTR 5,58 € -3,46%
Découvrez l'offre de courtage EasyBourse

Les dernières tendances

Paris

Liste des valeurs suivies vendredi à la Bourse de Paris, où le CAC 40 a clôturé en baisse de 0,82% à 3.729,36 points. Sur la semaine, l'indice a perdu 2,01%. * TOTAL (-1,38% à...

Wall Street

Les valeurs américaines ont fini en baisse vendredi pour la troisième séance d'affilée, les investisseurs anticipant une reprise économique anémique après les résultats jugés...

Tokyo

La Bourse de Tokyo a clôturé vendredi à un plus bas de quatre mois, affichant sa quatrième semaine de recul d'affilée, la plus longue série de baisses depuis septembre-octobre...

Devises

Le manque d'appétit pour le risque sur les marchés mondiaux profite au dollar et au yen en Europe vendredi.
Ce climat...

Pétrole

Les cours du pétrole ont à nouveau fini en baisse en parallèle aux prises de bénéfices sur les marchés d'actions. Sur le New York Mercantile Exchange, le contrat décembre sur le...

Taux

Les prix des emprunts d'Etat de la zone euro sont en légère baisse vendredi, alors que la Banque centrale européenne a fait un premier...